Can PET-CT scans better predict breast cancer treatment success?
NCT ID NCT07173868
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing whether a special type of PET-CT scan (F-18 FDG PET-CT) can better track how well treatment is working in people with advanced breast cancer compared to standard imaging like CT scans. Researchers will follow 100 patients for 48 weeks after they start their first systemic therapy. The goal is to see if the PET-CT scan gives a clearer picture of treatment response, which could help doctors make better decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- F-18 FDG PET-CT imaging
- What this could lead to
- If successful, this could show that PET-CT scans are better than standard imaging at predicting outcomes, potentially guiding more personalized treatment decisions.
- What could go wrong
- This is an observational study with only 100 participants, so results may not apply to all patients. It compares imaging methods, not treatments, so it won't directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung medical Center
RECRUITINGSeoul, Gannam-gu, 06351, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Can a pill combo outpace chemotherapy for aggressive breast cancer?
- Blood tests could reveal hidden resistance in breast cancer
- Triple threat: three new targeted drugs join forces with immunotherapy to attack Hard-to-Treat breast cancer
- New drug sequence aims to outsmart advanced breast cancer
- Could a pill replace an IV for advanced breast cancer treatment?